Improved prognosis in most common cancer at all stages

Malignant melanoma is one of the most common malignant tumors, especially in adolescent age groups. However, given the state of knowledge on the proliferation and antigenicity pattern of tumor cells, an ideal use of modern immunotherapeutic and targeted approaches is offered. Meanwhile, expansion of treatment options to early stages and in the neoadjuvant setting has improved recurrence- and progression-free survival.